Hikiami, Ryota
Morimura, Toshifumi
Ayaki, Takashi
Tsukiyama, Tomoyuki
Morimura, Naoko
Kusui, Makiko
Wada, Hideki
Minamiyama, Sumio
Shodai, Akemi
Asada-Utsugi, Megumi
Muramatsu, Shin-ichi
Ueki, Takatoshi
Takahashi, Ryosuke
Urushitani, Makoto
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP20K22682)
Shiga University of Medical Science (Intramural Research Fund)
National Center of Neurology and Psychiatry (Intramural Research Fund)
Article History
Received: 12 June 2022
Accepted: 13 September 2022
First Online: 26 September 2022
Competing interests
: S.M. owns equity in the Gene Therapy Research Institution (a gene therapy company) that commercializes the use of AAV vectors for gene therapy applications. Other authors declare there are no conflicts of interest.